Medigen Partners with France's Substipharm to Introduce Enterovirus Vaccine to ASEAN Markets

Medigen Vaccine Biologics Corporation announced on January 9 that it has signed a regional distribution agreement with French pharmaceutical company Substipharm Biologics. The partnership aims to expand the market for Medigen's enterovirus vaccine in Southeast Asia. The two companies have already finalized a distribution agreement for the "ENVACGEN Enterovirus 71 Vaccine" in Vietnam and will continue negotiations to introduce the vaccine in Thailand, the Philippines, Indonesia, Malaysia, and Singapore. This collaboration seeks to accelerate the delivery of high-quality, safe enterovirus 71 vaccines to ASEAN countries.